Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit

Keyphrases

• Adenocarcinoma 60%
• Antigen Expression 20%
• Apoptosis 20%
• Chemoprevention 20%
• Euthanized 20%
• Growth Factors 20%
• Hypertrophy 20%
• Insulin-like 20%
• Lesion Progression 20%
• Methyl 100%
• Methylseleninic Acid 100%
• Methylselenocysteine 60%
• Mouse Prostate 60%
• Neuroendocrine Carcinoma 20%
• Oncogenesis 20%
• Oral Dose 20%
• Prostate Cancer 40%
• Prostate Carcinogenesis 100%
• Prostate Lesions 20%
• Selenium Compounds 100%
• Seminal Vesicle 20%
• Serum Alanine Aminotransferase 20%
• Survival Benefit 100%
• Synaptophysin 40%
• T Antigen 20%
• Transgenic 60%
• Transgenic Adenocarcinoma of Mouse Prostate 100%
• Wild Mice 20%
• Young Males 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Adenocarcinoma 100%
• Alanine Aminotransferase 12%
• C57BL 6 Mouse 12%
• Carcinogenesis 100%
• Disease 12%
• Mouse 100%
• Prostate Cancer 25%
• Selenium Compound 100%
• Selenomethionine 12%
• Somatomedin C 12%
• Synaptophysin 25%
• Wild Type Mouse 12%